Clinical Trials
19 trialsNCT06068400 2026-03-17
Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Phase NA Terminated
NCT01794572 2025-12-12
TOMMY
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT00968799 2023-08-08
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Cantonal Hospital of St. Gallen
Phase NA Terminated
NCT05247957 2023-01-13
NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Hangzhou Cheetah Cell Therapeutics Co., Ltd
Phase NA Terminated
NCT03630653 2022-04-25
FIGARO
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT00816582 2021-11-16
PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer
British Columbia Cancer Agency
Phase NA Terminated
NCT02614157 2021-02-01
Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer
West China Hospital
Phase NA Terminated
NCT01486134 2020-05-13
ARMTICH
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT02566421 2018-07-02
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
Wake Forest University Health Sciences
Phase NA Terminated
NCT00504699 2018-03-29
Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients
New York Medical College
Phase NA Terminated
NCT00290628 2017-11-29
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00591305 2017-05-18
New Therapy of Laryngeal Papilloma In Children
Boston University
Phase NA Terminated
NCT01841021 2017-01-19
Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT00255684 2016-11-03
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
University of Rochester
Phase NA Terminated
NCT01517347 2016-10-24
Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation
Peking University People's Hospital
Phase NA Terminated
NCT00966498 2013-12-11
Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors
Emory University
Phase NA Terminated
NCT00301860 2013-07-15
Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
University of California, San Francisco
Phase NA Terminated
NCT00253552 2012-05-28
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
OHSU Knight Cancer Institute
Phase NA Terminated
NCT00631059 2010-10-13
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients
University of California, Irvine
Phase NA Terminated